Isolated isochromosome 17q

A distinct type of mixed myeloproliferative disorder/myelodysplastic syndrome with an aggressive clinical course

R. F. McClure, G. W. Dewald, James Hoyer, Curtis A. Hanson

Research output: Contribution to journalArticle

52 Citations (Scopus)

Abstract

A clinicopathologic study was performed on 15 patients with haematological malignancies in which isochromosome 17q [i(17q)] was the sole structural chromosome abnormality identified in bone marrow. The data indicated that an isolated i(17q) is associated with a distinct type of mixed chronic myeloproliferative/myelodysplastic disorder with an aggressive clinical course. The patients ranged in age from 37 to 83 years (median 60) with a M:F ratio of 3:1. All cases were chronic myeloid disorders with mixed proliferative and dysplastic features, making classification difficult. 11 patients tested for BCR/ABL gene fusion were normal. A low bone marrow blast count (<5%) at presentation was a typical finding. All cases had severe myeloid dysplasia which included non-segmented neutrophils and an increase in the monocyte/macrophage lineage. Fluorescence in situ hybridization (FISH) analysis of one case showed the i(17q) to involve all myeloid lineages, but not the lymphocytes. For cases with complete follow-up (n = 11) the median survival was 2.5 years (range 0.83-5.25) and 64% progressed to AML prior to death. The following features were identified which defined the haematological disorder associated with an isolated i(17q): (1) adult patient, (2) chronic myeloid disorder with clonal involvement of all myeloid lineages, (3) mixed chronic myeloproliferative/myelodysplastic features, (4) severe hyposegmentation of neutrophil nuclei, (5) prominence of the monocyte/macrophage lineage, (6) high risk for progression to AML, and (7) median survival of 2-5 years.

Original languageEnglish (US)
Pages (from-to)445-454
Number of pages10
JournalBritish Journal of Haematology
Volume106
Issue number2
DOIs
StatePublished - 1999

Fingerprint

Isochromosomes
Myeloproliferative Disorders
Myelodysplastic Syndromes
Monocytes
Neutrophils
Bone Marrow
Macrophages
Survival
Gene Fusion
Hematologic Neoplasms
Fluorescence In Situ Hybridization
Chromosome Aberrations
Lymphocytes

Keywords

  • Chronic myeloproliferative disorder
  • Isochromosome 17q
  • Myelodysplastic syndrome
  • Pseudo-Pelger-Huet neutrophils

ASJC Scopus subject areas

  • Hematology

Cite this

Isolated isochromosome 17q : A distinct type of mixed myeloproliferative disorder/myelodysplastic syndrome with an aggressive clinical course. / McClure, R. F.; Dewald, G. W.; Hoyer, James; Hanson, Curtis A.

In: British Journal of Haematology, Vol. 106, No. 2, 1999, p. 445-454.

Research output: Contribution to journalArticle

@article{2d40b000536a47db96f471f4cd46ecf0,
title = "Isolated isochromosome 17q: A distinct type of mixed myeloproliferative disorder/myelodysplastic syndrome with an aggressive clinical course",
abstract = "A clinicopathologic study was performed on 15 patients with haematological malignancies in which isochromosome 17q [i(17q)] was the sole structural chromosome abnormality identified in bone marrow. The data indicated that an isolated i(17q) is associated with a distinct type of mixed chronic myeloproliferative/myelodysplastic disorder with an aggressive clinical course. The patients ranged in age from 37 to 83 years (median 60) with a M:F ratio of 3:1. All cases were chronic myeloid disorders with mixed proliferative and dysplastic features, making classification difficult. 11 patients tested for BCR/ABL gene fusion were normal. A low bone marrow blast count (<5{\%}) at presentation was a typical finding. All cases had severe myeloid dysplasia which included non-segmented neutrophils and an increase in the monocyte/macrophage lineage. Fluorescence in situ hybridization (FISH) analysis of one case showed the i(17q) to involve all myeloid lineages, but not the lymphocytes. For cases with complete follow-up (n = 11) the median survival was 2.5 years (range 0.83-5.25) and 64{\%} progressed to AML prior to death. The following features were identified which defined the haematological disorder associated with an isolated i(17q): (1) adult patient, (2) chronic myeloid disorder with clonal involvement of all myeloid lineages, (3) mixed chronic myeloproliferative/myelodysplastic features, (4) severe hyposegmentation of neutrophil nuclei, (5) prominence of the monocyte/macrophage lineage, (6) high risk for progression to AML, and (7) median survival of 2-5 years.",
keywords = "Chronic myeloproliferative disorder, Isochromosome 17q, Myelodysplastic syndrome, Pseudo-Pelger-Huet neutrophils",
author = "McClure, {R. F.} and Dewald, {G. W.} and James Hoyer and Hanson, {Curtis A.}",
year = "1999",
doi = "10.1046/j.1365-2141.1999.01537.x",
language = "English (US)",
volume = "106",
pages = "445--454",
journal = "British Journal of Haematology",
issn = "0007-1048",
publisher = "Wiley-Blackwell",
number = "2",

}

TY - JOUR

T1 - Isolated isochromosome 17q

T2 - A distinct type of mixed myeloproliferative disorder/myelodysplastic syndrome with an aggressive clinical course

AU - McClure, R. F.

AU - Dewald, G. W.

AU - Hoyer, James

AU - Hanson, Curtis A.

PY - 1999

Y1 - 1999

N2 - A clinicopathologic study was performed on 15 patients with haematological malignancies in which isochromosome 17q [i(17q)] was the sole structural chromosome abnormality identified in bone marrow. The data indicated that an isolated i(17q) is associated with a distinct type of mixed chronic myeloproliferative/myelodysplastic disorder with an aggressive clinical course. The patients ranged in age from 37 to 83 years (median 60) with a M:F ratio of 3:1. All cases were chronic myeloid disorders with mixed proliferative and dysplastic features, making classification difficult. 11 patients tested for BCR/ABL gene fusion were normal. A low bone marrow blast count (<5%) at presentation was a typical finding. All cases had severe myeloid dysplasia which included non-segmented neutrophils and an increase in the monocyte/macrophage lineage. Fluorescence in situ hybridization (FISH) analysis of one case showed the i(17q) to involve all myeloid lineages, but not the lymphocytes. For cases with complete follow-up (n = 11) the median survival was 2.5 years (range 0.83-5.25) and 64% progressed to AML prior to death. The following features were identified which defined the haematological disorder associated with an isolated i(17q): (1) adult patient, (2) chronic myeloid disorder with clonal involvement of all myeloid lineages, (3) mixed chronic myeloproliferative/myelodysplastic features, (4) severe hyposegmentation of neutrophil nuclei, (5) prominence of the monocyte/macrophage lineage, (6) high risk for progression to AML, and (7) median survival of 2-5 years.

AB - A clinicopathologic study was performed on 15 patients with haematological malignancies in which isochromosome 17q [i(17q)] was the sole structural chromosome abnormality identified in bone marrow. The data indicated that an isolated i(17q) is associated with a distinct type of mixed chronic myeloproliferative/myelodysplastic disorder with an aggressive clinical course. The patients ranged in age from 37 to 83 years (median 60) with a M:F ratio of 3:1. All cases were chronic myeloid disorders with mixed proliferative and dysplastic features, making classification difficult. 11 patients tested for BCR/ABL gene fusion were normal. A low bone marrow blast count (<5%) at presentation was a typical finding. All cases had severe myeloid dysplasia which included non-segmented neutrophils and an increase in the monocyte/macrophage lineage. Fluorescence in situ hybridization (FISH) analysis of one case showed the i(17q) to involve all myeloid lineages, but not the lymphocytes. For cases with complete follow-up (n = 11) the median survival was 2.5 years (range 0.83-5.25) and 64% progressed to AML prior to death. The following features were identified which defined the haematological disorder associated with an isolated i(17q): (1) adult patient, (2) chronic myeloid disorder with clonal involvement of all myeloid lineages, (3) mixed chronic myeloproliferative/myelodysplastic features, (4) severe hyposegmentation of neutrophil nuclei, (5) prominence of the monocyte/macrophage lineage, (6) high risk for progression to AML, and (7) median survival of 2-5 years.

KW - Chronic myeloproliferative disorder

KW - Isochromosome 17q

KW - Myelodysplastic syndrome

KW - Pseudo-Pelger-Huet neutrophils

UR - http://www.scopus.com/inward/record.url?scp=0032870994&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032870994&partnerID=8YFLogxK

U2 - 10.1046/j.1365-2141.1999.01537.x

DO - 10.1046/j.1365-2141.1999.01537.x

M3 - Article

VL - 106

SP - 445

EP - 454

JO - British Journal of Haematology

JF - British Journal of Haematology

SN - 0007-1048

IS - 2

ER -